G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 38.6 NOK -2.28%
Market Cap: kr595.2m

Wall Street
Price Targets

GENT Price Targets Summary
Gentian Diagnostics ASA

Wall Street analysts forecast GENT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENT is 64.26 NOK with a low forecast of 63.63 NOK and a high forecast of 66.15 NOK.

Lowest
Price Target
63.63 NOK
65% Upside
Average
Price Target
64.26 NOK
66% Upside
Highest
Price Target
66.15 NOK
71% Upside
Gentian Diagnostics ASA Competitors:
Price Targets
MRNA
Moderna Inc
-19% Downside
PINT
Pantheon Infrastructure PLC
11% Upside
9636
JF Wealth Holdings Ltd
82% Upside

Revenue
Forecast

26% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
26% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 8 years the compound annual growth rate for Gentian Diagnostics ASA's revenue is 26%. The projected CAGR for the next 3 years is 21%.

Operating Income
Forecast

N/A
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Gentian Diagnostics ASA's operating income for the next 4 years is 50%.

Net Income
Forecast

N/A
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

The compound annual growth rate of Gentian Diagnostics ASA's net income for the next 2 years is -4%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENT's stock price target?
Price Target
64.26 NOK

According to Wall Street analysts, the average 1-year price target for GENT is 64.26 NOK with a low forecast of 63.63 NOK and a high forecast of 66.15 NOK.

What is Gentian Diagnostics ASA's Revenue forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Gentian Diagnostics ASA's revenue is 26%. The projected CAGR for the next 3 years is 21%.

What is Gentian Diagnostics ASA's Operating Income forecast?
Projected CAGR
50%

The compound annual growth rate of Gentian Diagnostics ASA's operating income for the next 4 years is 50%.

What is Gentian Diagnostics ASA's Net Income forecast?
Projected CAGR
-4%

The compound annual growth rate of Gentian Diagnostics ASA's net income for the next 2 years is -4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett